[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MattBiotech Matthew Gamber
Matthew Gamber posts on X about $nvs, $stml, $idya, $ctic the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +15%
- X Month XXXXXX +804%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX +15%
Mentions: X #
- X Week X -XX%
- X Month XX -XXXX%
- X Months XX -XX%
- X Year XXX +3.10%
Followers: XXXXX #
- X Week XXXXX +0.82%
- X Month XXXXX +2.50%
- X Months XXXXX +11%
- X Year XXXXX +17%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks
Social topic influence $nvs, $stml, $idya, $ctic, mf, $mnkd, $pfe, $celc, $jnj, $cdtx
Top assets mentioned Novartis AG (NVS) IDEAYA Biosciences, Inc. Common Stock (IDYA) Pfizer, Inc. (PFE) Johnson & Johnson (JNJ)
Top Social Posts #
Top posts by engagements in the last XX hours
"@plainyogurt21 @EpochSwing Exploratory analysis to be fair. Yeah obviously not without risk but all of the people hired cut their teeth at decidedly better companies like $NVS $STML $IDYA $CTIC.clear goal to improve sales near-term get to the MF readout then sell the company"
X Link @MattBiotech 2025-10-15T19:42Z 5416 followers, XXX engagements
"Two days ago I posted an article for subscribers where I pitched $MNKD as a long. I thought I would write it up here too since I don't use this platform much anymore. I even bought X premium so hopefully this is worth $X. 😬 $MNKD as I write this: $XXXX share price $XXXX billion valuation. First things first I know $MNKD has about a very bad record of shareholder return and dilution. If they didnt have the reputation they do I think it would trade 1.5x to 2x higher. But it is what it is. If investors know them from anything now its just as the Tyvaso royalty company. But theres actually a lot"
X Link @MattBiotech 2025-09-25T13:00Z 5411 followers, 5182 engagements
"There should be a website cataloguing all the missteps Big Pharma have made it partnerships. Recent top of mind examples: $PFE licensing $CELC drug for $XX million in cash/equity $CELC now $X billion mkt cap (there are some milestones tho) $JNJ returning $CDTX drug to them for basically free $CDTX now $2.55b market cap Obviously they are right more often than wrong but the wrong times look reaaaaaaaally bad"
X Link @MattBiotech 2025-10-08T15:40Z 5415 followers, 9313 engagements